£1.5M
The financing will support clinical material manufacture and preparation for regulatory studies ahead of a target marketing authorisation application.
1nhaler
Developer of a novel paper-based dry powder inhaler platform.
£3.5MTotal raised
1nhaler develops a single-dose dry powder inhaler made predominantly from cardboard. The credit card sized device uses a patented membrane system to deliver medications sustainably.
Categories
Founders
DS
Don Smith
LM
Lisa McMyn
Chief Executive Officer
Investors
- £1.5M
- £2.0M
Funding history
£2.0M
The investment round was led by Archangels with participation from Dr Yusuf Hamied, British Business Investments, and seed investors.